Early research (Phase 1)Study completedNCT00993044
What this trial is testing
Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
Who this might be right for
Refractory Solid Tumors in Children
Children's Hospital Los Angeles 13